TIMOTHY A. SPRINGER - 13 Jan 2025 SCHEDULE 13D/A Report for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

Filing Manager
TIMOTHY A. SPRINGER
Reporting Manager
Timothy A. Springer
Security
Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RNAC
Shares outstanding
25.9M shares
Disclosed Ownership
9.56M shares
Ownership
36.9%
Form type
SCHEDULE 13D/A
Filing time
15 Jan 2025, 16:25:12 UTC
Date of event
13 Jan 2025
Previous filing
23 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Timothy A. Springer 36.9% 9.56M 9.56M 0 /s/ Timothy A. Springer Timothy A. Springer 0001055624
TAS Partners LLC 2.2% 563K 563K 0 /s/ Timothy A. Springer Timothy A. Springer/Manager 0001677543
Chafen Lu 1.4% 351K 351K 0 /s/ Chafen Lu Chafen Lu